SEC FORM 4CLUSTER · 5 INSIDERS
$1,566,346.71
Rapport Therapeutics, Inc. (RAPP)
Purchase of 58,094 shares across 5 reporting persons.
Transaction Code P · Reporting Persons 5
- Ignelzi Troy A., Chief Financial OfficerPurchase of 5,500 shares at $26.10 per share.$143,550.00
- MARAGANORE JOHNPurchase of 8,239 shares at $26.3799 per share.$217,344.00
- MARAGANORE JOHNPurchase of 1,172 shares at $26.9173 per share.$31,547.08
- PAUL STEVEN MPurchase of 35,714 shares at $27.28 per share.$974,277.92
- Young Wendy B.Purchase of 3,789 shares at $26.39 per share.$99,991.71
- Silva Paul MPurchase of 3,680 shares at $27.075 per share.$99,636.00
Surfaced by rule: 5 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Oct 21, 2026 · Disclosed Oct 22, 2026
Source: SEC Form 4 · 0001193125-26-428018 · filed 2026-10-21 · View filing →
Source: SEC Form 4 · 0001193125-26-429071 · filed 2026-10-22 · View filing →
Source: SEC Form 4 · 0001193125-26-429073 · filed 2026-10-22 · View filing →
Source: SEC Form 4 · 0001193125-26-429074 · filed 2026-10-22 · View filing →
Source: SEC Form 4 · 0001193125-26-429075 · filed 2026-10-22 · View filing →